Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Annals of Oncology
Journal
Overview
Identity
Overview
Publication Venue For
FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies
. 33:522-533.
2022
Distinct genomic landscapes of gastroesophageal adenocarcinoma depending on PD-L1 expression identify mutations in RAS–MAPK pathway and TP53 as potential predictors of immunotherapy efficacy
. 32:906-916.
2021
Disparities in clinical outcomes across age, sex and race among patients with pancreatic adenocarcinoma: a single center experience
. 30:iv64.
2019
Efficacy and tolerability of the combination of Liposomal irinotecan and 5-fluorouracil/leucovorin in advanced pancreatic cancers: post-approval clinic experience
. 30:iv74.
2019
Neoadjuvant modified FOLFIRINOX or gemcitabine-nab paclitaxel followed by stereotactic body radiotherapy for patients with locally advanced pancreatic cancer
. 30:iv67.
2019
Outcomes of Gastrointestinal cancers treated on Phase 1 clinical trials at O'Neal Comprehensive Cancer Center
. 30:iv66.
2019
Ramucirumab plus merestinib in previously treated metastatic colorectal cancer: safety, pharmacokinetic, and preliminary efficacy findings from a Phase 1 study
. 30:iv124.
2019
Stereotactic body radiotherapy in locally advanced pancreatic adenocarcinoma: A single institution experience
. 30:iv89.
2019
Bevacizumab-induced radiosenitzation in small cell lung cancer
. 29:ix148.
2018
First report of real-world patient characteristics and treatment patterns from POLARIS: Palbociclib in hormone receptor-positive (HR+) advanced breast cancer: A prospective, multicenter, noninterventional study
. 29:viii112-viii113.
2018
Phase Ib/II, open label, multicenter study of intratumoral SD-101 in combination with pembrolizumab in anti-PD-1 treatment naïve patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC)
. 29:viii375.
2018
Results of phase II trial of SL-701, a novel immunotherapy targeting IL-13Ra2, EphA2, and survivin, in adults with second-line recurrent glioblastoma (GBM)
. 29:viii122-viii123.
2018
Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: Final results from the PILLAR-2 randomized phase III trial
. 29:707-714.
2018
Multi-institutional competing risks analysis of distant brain failure and salvage patterns after upfront radiosurgery without whole brain radiotherapy for brain metastasis
. 29:497-503.
2018
Non-coding MIR491 is associated with less EGFr expression and greater radiosensitivity in human head and neck cancer cell lines
. 28:x6.
2017
Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide
. 28:2264-2271.
2017
Efficacy of a novel antibody-drug conjugate (ADC), ABT-414, with temozolomide (TMZ) in recurrent glioblastoma (rGBM)
. 27:vi103.
2016
Hyponatremia and hypoalbuminemia as predictive factors for response to first line treatment for metastatic non-small cell lung cancer
. 27:vi36.
2016
Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial
. 27:1041-1047.
2016
Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors
. 26:1481-1487.
2015
Screening for the Prevalence of EGFR and Alk Mutations in Lung Adenocarcinoma Patients in the Levant Area, a Prospective Analysis
. 26:i1-i1.
2015
Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303)
. 25:2036-2041.
2014
A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors
. 25:1416-1421.
2014
Acute leukemia and myelodysplasia after adjuvant chemotherapy for breast cancer: Durable remissions after hematopoietic stem cell transplantation
. 20:2000-2006.
2009
Race and ethnicity correlate with survival in patients with gastric adenocarcinoma
. 21:152-160.
2009
Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer
. 20:1242-1248.
2009
A randomized, phase II trial of two dose schedules of carboplatin/ paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC)
. 20:1068-1073.
2009
Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): A meta-analysis of individual data from 1764 patients
. 17:473-483.
2006
An endogastric capsule for measuring tumor markers in gastric juice: An evaluation of the safety and efficacy of a new diagnostic tool
. 14:105-109.
2003
Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy
. 12:109-114.
2001
Identity
International Standard Serial Number (issn)
0923-7534
Electronic International Standard Serial Number (eissn)
1569-8041